Market Tracker

04/17 6:05pm ET

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

5.88
Data as of Apr 17
 +0.18 / +3.16%
Today’s Change
3.10
Today|||52-Week Range
10.64
+55.97%
Year-to-Date
No recent news for Northwest Biotherapeutics Inc.

Today’s Trading

Previous close5.70
Today’s open5.84
Day’s range5.50 - 5.96
Volume438,908
Average volume (3 months)1,257,921
Market cap$368.1M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-2.14%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+7,620.00%
P/E ratioNM
Price/Sales47.52
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd-0.01-0.16%
AKBAAkebia Therapeutics ...+1.39+5.63%
ZGNXZogenix Inc-0.11-3.90%
SUPNSupernus Pharmaceuti...+0.07+0.85%
Data as of 3:59pm ET, 04/17/2014

Financials

Next reporting dateMay 15, 2014
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$772.0K
Annual profit (last year)-$67.3M
Net profit margin-8,720.21%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Linda F. Powers
Chief Operating Officer
Anthony E. Maida
Corporate headquarters
Bethesda, Maryland

Forecasts